Vaccine News and Research

Latest Vaccine News and Research

U.N. officials highlight need for vaccine assistance to poor countries

U.N. officials on Sunday said that the H1N1 (swine flu) virus had arrived in poorer countries, highlighting a growing need for financial assistance and H1N1 vaccines for such regions, SAPA/News24.com reports.

6 Oct 2009

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

As the first recipients of the H1N1 vaccine are vaccinated, more than half of Americans surveyed (52 percent) do not believe the H1N1 virus, or Swine Flu, will have a major impact in the United States compared to 44 percent who believe it will, according to the results of a new Deloitte Center for Health Solutions survey.

6 Oct 2009

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced today that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV.

5 Oct 2009

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

5 Oct 2009

American Lung Association kicks off its Faces of Influenza campaign in Miami

The American Lung Association of Florida-South Area is kicking off its 2009-2010 Faces of Influenza initiative by conducting a public influenza panel discussion to help Miami area residents understand the seriousness of seasonal influenza and the importance of annual vaccination. The meeting will address the latest flu statistics and benefits of vaccination, especially among high-risk groups.

3 Oct 2009

HSPH's survey on H1N1 vaccines

In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.

3 Oct 2009

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

In response to the shortage of Tamiflu in liquid form, all 795 Publix Pharmacies will offer to compound Tamiflu into an oral suspension.

3 Oct 2009

Surgical masks appear as effective as N95 respirators against influenza: Study

A McMaster University study has found that surgical masks appear to be as good as N95 respirators in protecting health-care workers against influenza.

3 Oct 2009

Chinese government places second purchase order for Sinovac Biotech's H1N1 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that Sinovac has received its second purchase order for its H1N1 vaccine, PANFLU.1, from the Ministry of Industry and Information Technology of the People's Republic of China for the national stockpiling plan.

3 Oct 2009

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

The optimal way to control swine flu, the new H1N1 virus that emerged as a global threat in 2009, is to vaccinate children with the planned H1N1 flu vaccine, says the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

3 Oct 2009

90% of public support H1N1 vaccination for health care workers

As H1N1 influenza vaccine begins to be shipped across the country, the Centers for Disease Control and Prevention emphasize getting the first doses to high-priority groups. One such group is health care workers.

3 Oct 2009

DelSite's assests acquired by Nanotherapeutics

Nanotherapeutics, Inc., a privately held specialty biopharmaceutical company, announced today that it had acquired certain assets from DelSite (formerly Carrington Laboratories, Inc.) out of Chapter 7 bankruptcy proceedings in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.

3 Oct 2009

Face mask: A vital tool in fighting H1N1

With flu season officially underway on October 4th, Cantel Medical Corp., a company dedicated to infection prevention and control, recommends that Americans take extra precautions against spreading H1N1 influenza. Crosstex International, a subsidiary of Cantel Medical, is one of the largest U.S. manufacturers of face masks.

3 Oct 2009

Interim results of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine clinical trials announced

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults 18 years through 64 years of age and over the age of 65 years.

3 Oct 2009

Researchers screen decades-old frozen infant stool samples to detect norovirus

A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

3 Oct 2009

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

Baxter International Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) granted its “positive opinion” for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. This positive opinion confirms the acceptability of Baxter’s regulatory submission to obtain final marketing authorization and licensure of the product.

From Baxter International Inc. 3 Oct 2009

First U.S. patients could receive H1N1 vaccine next week

U.S. health officials announced Thursday the first batches of the H1N1 (swine flu) vaccine the government ordered will begin arriving in designated locations across the country on Tuesday and may be administered in the first patients by the end of next week, Reuters reports (Fox, 10/1).

3 Oct 2009

Vaccine News and Research

Latest Vaccine News and Research

U.N. officials highlight need for vaccine assistance to poor countries

Research reveals that 52% Americans are not worried about H1N1 virus and its impact

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

American Lung Association kicks off its Faces of Influenza campaign in Miami

HSPH's survey on H1N1 vaccines

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

Surgical masks appear as effective as N95 respirators against influenza: Study

Chinese government places second purchase order for Sinovac Biotech's H1N1 vaccine

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

90% of public support H1N1 vaccination for health care workers

DelSite's assests acquired by Nanotherapeutics

Face mask: A vital tool in fighting H1N1

Interim results of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine clinical trials announced

Researchers screen decades-old frozen infant stool samples to detect norovirus

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

First U.S. patients could receive H1N1 vaccine next week

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in